Zhejiang Huahai Pharmaceutical Co., Ltd.

XSSC:600521 Stock Report

Market Cap: CN¥27.2b

Zhejiang Huahai Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Huahai Pharmaceutical has a total shareholder equity of CN¥9.0B and total debt of CN¥6.9B, which brings its debt-to-equity ratio to 77.1%. Its total assets and total liabilities are CN¥19.6B and CN¥10.6B respectively. Zhejiang Huahai Pharmaceutical's EBIT is CN¥1.8B making its interest coverage ratio 10.7. It has cash and short-term investments of CN¥1.5B.

Key information

77.1%

Debt to equity ratio

CN¥6.91b

Debt

Interest coverage ratio10.7x
CashCN¥1.52b
EquityCN¥8.95b
Total liabilitiesCN¥10.60b
Total assetsCN¥19.56b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600521's short term assets (CN¥8.0B) exceed its short term liabilities (CN¥5.7B).

Long Term Liabilities: 600521's short term assets (CN¥8.0B) exceed its long term liabilities (CN¥4.9B).


Debt to Equity History and Analysis

Debt Level: 600521's net debt to equity ratio (60.2%) is considered high.

Reducing Debt: 600521's debt to equity ratio has increased from 76.8% to 77.1% over the past 5 years.

Debt Coverage: 600521's debt is well covered by operating cash flow (38.3%).

Interest Coverage: 600521's interest payments on its debt are well covered by EBIT (10.7x coverage).


Balance Sheet


Discover healthy companies